NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Palbociclib in Patients with Tumors Harboring Activating Alterations in Cell Cycle Genes
-
Enrollment
This study is not currently enrolling. -
Associated Conditions
-
Research Area
Pediatrics Research -
Principal Investigator
-
Sponsor
Children's Oncology Group
The main goal of this study is to test any good and bad effects of the palbociclib on your tumor. A second goal of the study is to evaluate side effects that might be caused by palbociclib.